Search

Search Constraints

You searched for: Date 2023 Author/Creator Katanuma, Akio

Search Results

2. A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407). (March 2023)

3. Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial. Issue 10372 (21st January 2023)